Updates

Strix

August 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Strix’s trading update for H1 said total exposure to the Russia-Ukraine conflict is now estimated to be c.£5m-£7m of revenues for FY22. This is because peripheral states are beginning to experience spill over consequences in terms of levels of demand and logistical challenges. Despite that it said FY22 post-tax profit will be in line with the consensus estimate of £32.2m, although this year will see an H2 weighting to profitability. Zeus forecasts eps of 15.4p and a dividend of 8.6p for the year. Results are on 21 September. Strix remains a quality business and a big buy opportunity is looming at some point. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

AlphaFX - Going like a train

T Clarke

Strix (August 2023)

Strix (January 2023)

Strix - Buys Billi for £38m (November 2022)

Strix (October 2022)

Strix - Faster growth from water and SDA divisions (October 2021)

Strix (August 2021)

Strix - Strategy to double sales by 2025 (May 2021)

Strix (October 2019)

Strix (August 2018)

Strix (May 2018)

Strix - Whos who of institutional buyers (September 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X